<p>Ascletis Pharma Inc. has filed a next day disclosure return with the Hong Kong Stock Exchange, reporting the repurchase of 200,000 ordinary shares at a total aggregate price of HKD 2,482,860. The shares were repurchased for cancellation. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ascletis Pharma Inc. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20251229-11968988), on December 29, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT)</p>

01672

<p>Ascletis Pharma Inc. has repurchased 200,000 ordinary shares for a total of HKD 2.48 million, as disclosed in a filing with the Hong Kong Stock Exchange. The shares are intended for cancellation. This information is part of a next day disclosure return.</p>

Ascletis Pharma Repurchases 200,000 Shares for HK$2.48 Million in HKEX Filing